Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...

The Series B round saw strong participation from both existing and new investors, demonstrating high industry confidence in ...

News Design Manufacturing ENR 2025 Top 500 Sourcebook: Expanding Pharmaceutical Production Jacobs leads work on Fujifilm's cell culture manufacturing plant, and its first addition ...

Arkansas defensive coordinator Travis Williams made his annual splash Wednesday evening when 2026 four-star linebacker JJ Bush of Theodore (Ala.) chose the Razorbacks over LSU and Missouri.

Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment o ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug costs and unfairly undermine independent pharmacies.

Why Ravens LB Kyle Van Noy is desperately seeking his first sack of new Steelers QB Aaron Rodgers Van Noy and Rodgers have a history, dating back to their time in the NFC North ...

The impact of pharmaceutical roundtripping on the trade balance is both too big to continue and too big to ignore. Time for some real changes.

A judge has advanced OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids.

The state of Maine is expected to receive $26 million from Purdue Pharma and its owners, the Sackler family, as part of the $7.4 billion settlement that will resolve lawsuits over the company's ...